Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System(TM)

Stock Information for Apyx Medical Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Apyx Medical Corporation

Renuvion® Brings Real Transformations to the Runway at Miami Swim Week
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System(TM)
Apyx Medical Corporation Reports First Quarter 2025 Financial Results
Renuvion Introduces Television Star Dolores Catania as Chief of Confidence
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.